Nadeem Riaz

This account is verified. Learn more

@xrtGenomics

Physician/Scientist. Head and Neck Oncologist (radiation). Interests in cancer genomics, immunotherapy & DNA repair. @MSKCancerCenter

New York, NY riazlab.org Joined May 2009

2K Following 2.3K Followers 2.1K Posts

Latest posts 5

Pinned post

Nadeem Riaz @xrtGenomics Jan 5

🥳🎆 Kicking of 2026 with our work showing intra-tumoral bacteria 🦠 affect outcomes of Radiotherapy + anti-PD-L1 now out in @NatureCancer with sister paper by @nataliesilvermd! Even when trials "fail" – we can learn from them! nature.com/articles/s4301…. -- w/ @GeneCollector, @imrtlee, @TylerAlban1, @DrHaddadRobert, the Pfizer team and more! (1/N)

www.nature.com Tumor ecosystem and microbiome features associated with efficacy and resistance to avelumab plus... Nature Cancer - Chan and colleagues report that tumor ecosystem and microbiome features are associated with response to anti-PD-L1 avelumab plus chemoradiotherapy in patients with locally advanced...

Nadeem Riaz @xrtGenomics Sep 29

#radonc has gigantic oppurtunity to improve care in metastatic cancer. But we need to understand our impact on the biology more — great session by @jeremy_setton @Samuel_Bakhoum , @CJTsaiMDPhD , @SeanPitroda — trying to unravel how to move biology in this space into the clinic #astro26

Daniel E Spratt Verified account @DrSpratticus Sep 26

#ASTRO26

Accela and the neo. Proud for @RadOncUH to be the first center in the world to enroll a patient on a trial with this amazing tech.

@DrAndrewLoblaw @alison_tree @ASTRO_org @AmarUKishan @cwspeers @DrewMoghanaki @freddyeescorcia @EvanThomas84 @EricTopol @montypal @neerajaiims @wandering_gu @PGrivasMDPhD @shilpaonc @TylerSbrt @DrChoueiri @piet_ost @sueyom @jamesbyu @NehaVapiwala @NRGonc @nytimes @washingtonpost @EricTopol @urotoday @SbrtSean

View quoted post on X

Nadeem Riaz @xrtGenomics Sep 28

No difference in overall survival with protons vs photons in OPC! Great work by our APP Ying! @imrtlee @seanmmcbride @yaoyu @CJTsaiMDPhD #astro26 #hncsm #radonc

Nadeem Riaz @xrtGenomics Sep 21

Most RT-drug combos bet on synergy. Yet synergy is rare (most combos only additive). We're chasing a bar most of oncology can't clear. Our phase 1s don't even measure it. ProjectOptimus for #RadOnc & our editorial in @IJROBP w/Gustav, Ezra & @imrtlee -
doi.org/10.1016/j.ijro…

Henning Willers, MD, FASTRO Verified account @HenningWillers Aug 8

Must listen and must read!!
See also accompanying commentary by Nadeem Riaz @xrtGenomics which should be out soon in @IJROBP
#RedJournal #radonc #radbio

@finn_corinne
@sueyom
View quoted post on X

Nadeem Riaz @xrtGenomics Aug 28

Agree PET/CT invaluable in post-op setting! But #hncm has a far way to go in standardizing imaging unfortunately. We can't even make PET/CT SoC for defintive rx! Maybe 25-50% of country still doesnt even get this pre-treat? In 2026! @CJTsaiMDPhD @sueyom @imrtlee @DavidSherMD @seanmmcbride

Yao Yu @yaoyu_md Aug 28

This is exactly what we found: post-op PET/CT sim detected early recurrence in 16.5% of resected OSCC pts vs 3.3% with CT alone (n=391, aOR 7.9). The highest risk was in the ECE/SM+ group, but the DFS/OS benefit was in intermediate-risk pts (HR 0.46). You can't unsee it

View quoted post on X